Cypress Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $24M | Sell |
22,336
-365
| -2% | -$349K | 5.28% | 4 |
|
|
2025
Q3 | $17.3M | Sell |
22,701
-243
| -1% | -$181K | 3.94% | 6 |
|
|
2025
Q2 | $17.9M | Buy |
22,944
+506
| +2% | +$393K | 4.31% | 5 |
|
|
2025
Q1 | $18.5M | Buy |
22,438
+466
| +2% | +$388K | 4.96% | 4 |
|
|
2024
Q4 | $17.3M | Buy |
21,972
+94
| +0.4% | +$77.8K | 4.29% | 4 |
|
|
2024
Q3 | $19.4M | Buy |
21,878
+402
| +2% | +$361K | 4.83% | 4 |
|
|
2024
Q2 | $19.8M | Sell |
21,476
-483
| -2% | -$386K | 5.09% | 4 |
|
|
2024
Q1 | $17.4M | Sell |
21,959
-330
| -1% | -$235K | 4.71% | 4 |
|
|
2023
Q4 | $13M | Buy |
22,289
+595
| +3% | +$347K | 3.91% | 3 |
|
|
2023
Q3 | $11.7M | Buy |
21,694
+60
| +0.3% | +$30.9K | 3.9% | 3 |
|
|
2023
Q2 | $10.2M | Sell |
21,634
-330
| -2% | -$138K | 3.27% | 4 |
|
|
2023
Q1 | $7.54M | Sell |
21,964
-621
| -3% | -$209K | 2.61% | 5 |
|
|
2022
Q4 | $8.26M | Sell |
22,585
-935
| -4% | -$332K | 3% | 5 |
|
|
2022
Q3 | $7.61M | Sell |
23,520
-313
| -1% | -$99.2K | 2.91% | 5 |
|
|
2022
Q2 | $7.73M | Sell |
23,833
-60
| -0.3% | -$18K | 2.76% | 5 |
|
|
2022
Q1 | $6.84M | Sell |
23,893
-3,918
| -14% | -$1.01M | 2.01% | 10 |
|
|
2021
Q4 | $7.68M | Sell |
27,811
-464
| -2% | -$118K | 1.83% | 12 |
|
|
2021
Q3 | $6.53M | Sell |
28,275
-170
| -0.6% | -$42K | 1.69% | 16 |
|
|
2021
Q2 | $6.53M | Sell |
28,445
-359
| -1% | -$72.1K | 1.67% | 15 |
|
|
2021
Q1 | $5.38M | Sell |
28,804
-678
| -2% | -$133K | 1.49% | 18 |
|
|
2020
Q4 | $4.98M | Sell |
29,482
-217
| -0.7% | -$32.4K | 1.39% | 19 |
|
|
2020
Q3 | $4.4M | Sell |
29,699
-295
| -1% | -$45.7K | 1.37% | 23 |
|
|
2020
Q2 | $4.92M | Sell |
29,994
-665
| -2% | -$102K | 1.64% | 14 |
|
|
2020
Q1 | $4.25M | Buy |
30,659
+76
| +0.2% | +$10.4K | 1.84% | 15 |
|
|
2019
Q4 | $4.02M | Sell |
30,583
-2,425
| -7% | -$281K | 1.37% | 22 |
|
|
2019
Q3 | $3.69M | Sell |
33,008
-1,127
| -3% | -$125K | 1.28% | 23 |
|
|
2019
Q2 | $3.78M | Sell |
34,135
-1,181
| -3% | -$139K | 1.29% | 23 |
|
|
2019
Q1 | $4.58M | Sell |
35,316
-3,744
| -10% | -$455K | 1.56% | 18 |
|
|
2018
Q4 | $4.52M | Sell |
39,060
-2,905
| -7% | -$325K | 1.69% | 15 |
|
|
2018
Q3 | $4.5M | Buy |
41,965
+1,785
| +4% | +$178K | 1.32% | 21 |
|
|
2018
Q2 | $3.43M | Sell |
40,180
-4,910
| -11% | -$403K | 1.01% | 32 |
|
|
2018
Q1 | $3.49M | Sell |
45,090
-16,776
| -27% | -$1.35M | 1.02% | 35 |
|
|
2017
Q4 | $5.22M | Sell |
61,866
-5,840
| -9% | -$497K | 1.12% | 29 |
|
|
2017
Q3 | $5.79M | Sell |
67,706
-5,540
| -8% | -$454K | 1.25% | 26 |
|
|
2017
Q2 | $6.03M | Sell |
73,246
-12,680
| -15% | -$1.03M | 1.24% | 27 |
|
|
2017
Q1 | $7.23M | Sell |
85,926
-5,205
| -6% | -$417K | 1.38% | 22 |
|
|
2016
Q4 | $6.7M | Buy |
91,131
+489
| +0.5% | +$36.4K | 1.29% | 24 |
|
|
2016
Q3 | $7.28M | Sell |
90,642
-470
| -0.5% | -$37.6K | 1.45% | 20 |
|
|
2016
Q2 | $7.17M | Buy |
91,112
+377
| +0.4% | +$28.4K | 1.43% | 20 |
|
|
2016
Q1 | $6.53M | Sell |
90,735
-267
| -0.3% | -$20.2K | 1.33% | 22 |
|
|
2015
Q4 | $7.67M | Buy |
91,002
+1,850
| +2% | +$154K | 1.54% | 19 |
|
|
2015
Q3 | $7.46M | Sell |
89,152
-125
| -0.1% | -$10.6K | 1.57% | 16 |
|
|
2015
Q2 | $7.45M | Sell |
89,277
-375
| -0.4% | -$28.6K | 1.4% | 21 |
|
|
2015
Q1 | $6.51M | Sell |
89,652
-3,100
| -3% | -$221K | 1.22% | 25 |
|
|
2014
Q4 | $6.4M | Buy |
92,752
+60
| +0.1% | +$4.05K | 1.18% | 25 |
|
|
2014
Q3 | $6.01M | Sell |
92,692
-2,725
| -3% | -$173K | 1.09% | 29 |
|
|
2014
Q2 | $5.93M | Sell |
95,417
-6,885
| -7% | -$411K | 1.02% | 33 |
|
|
2014
Q1 | $6.02M | Sell |
102,302
-4,810
| -4% | -$268K | 1.09% | 29 |
|
|
2013
Q4 | $5.46M | Sell |
107,112
-1,830
| -2% | -$91.6K | 0.95% | 33 |
|
|
2013
Q3 | $5.48M | Sell |
108,942
-1,330
| -1% | -$69.6K | 1.02% | 30 |
|
|
2013
Q2 | $5.42M | Buy |
+110,272
| New | +$6M | 1.01% | 29 |
|
Other funds holding LLY
Cypress Asset Management's LLY Position: Q4 2025 in Review
Cypress Asset Management reduced its Eli Lilly (LLY) stake by 1.6% in Q4 2025, selling an estimated $349K and leaving 22,336 shares worth $24M. The position accounts for 5.28% of the portfolio, ranked #4.
Cypress Asset Management first reported a position in LLY in Q2 2013 and has held it in 51 quarters since. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.
- Cypress Asset Management held 22,336 shares of Eli Lilly worth $24M as of Q4 2025.
- Cypress Asset Management sold 365 Eli Lilly shares in Q4 2025, an estimated $349K.
- Eli Lilly made up 5.28% of Cypress Asset Management's portfolio in Q4 2025, its #4 holding.
- Cypress Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 51 quarters since.
- 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.
Based on Cypress Asset Management's 13F filing for Q4 2025, filed 29 Jan 2026.